|
Diaz-Santa J, Rodriguez-Romanos R, Osca G, Pratcorona M, Garrido A, Coll R, Moret C, Escoda L, Tormo M, Heras I, Arnan M, Vives S, Salamero O, Lloveras N, Bargay J, Sampol A, Cruz D, Garcia A, Quinones T, Esteve J, Sierra J, Gallardo D; on the behalf of CETLAM Group. UGT1A1 genotype influences clinical outcome in patients with intermediate-risk acute myeloid leukemia treated with cytarabine-based chemotherapy. Leukemia. 2020 Nov;34(11):2925-2933. doi: 10.1038/s41375-020-0784-2. Epub 2020 Mar 9. PubMed PMID: 32152464.
AÑO: 2020; IF: 11.528
|
32152464
|
Martinez C, Carpio C, Heras I, Rios-Herranz E, Buch J, Gutierrez A, Romero S, Zeberio I, Garcia-Garcia I, Rodriguez-Izquierdo A, Alonso R, Bargay J, Barrenetxea C, Domingo-Domenech E, de Haro ME, Palomera L, Garcia-Sanz R; Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO). Potential Survival Benefit for Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation after Nivolumab Therapy for Relapse/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain. Biol Blood Marrow Transplant. 2020 Aug;26(8):1534-1542. doi: 10.1016/j.bbmt.2020.02.003. Epub 2020 Feb 14. PubMed PMID: 32068094.
AÑO: 2020; IF: 5.742
|
|
Amat P, Lopez-Corral L, Goterris R, Perez A, Lopez O, Heras I, Arbona C, Viguria MC, Hernandez-Boluda JC, Martinez-Ruiz F, Martinez A, Solano C. Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant. J Clin Apher. 2021 Oct;36(5):697-710. doi: 10.1002/jca.21918. Epub 2021 Jun 29. PubMed PMID: 34185332.
AÑO: 2021; IF: 2.605
|
|
Bento L, Gutierrez A, Novelli S, Montoro J, Pinana JL, Lopez-Corral L, Cabrero M, Martin-Sancho A, Gutierrez-Garcia G, Ortiz-Moscovich M, Bastos-Oreiro M, Dorado N, Perez A, Hernani R, Ferra C, Parody R, Garcia-Cadenas I, Herrera P, Rodriguez G, Rodriguez N, Martin C, Yanez L, Zanabili J, Varela MR, Lopez-Godino O, Heras I, Espanol I, Martinez C, Perez-Simon JA, Solano C, Sureda A, Sierra J, Sampol A, Caballero D; Grupo Espanol de Trasplante Hematopoyetico (GETH) and Grupo Espanol de Linfoma y Trasplante Autologo (GELTAMO). Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study. Bone Marrow Transplant. 2021 Aug;56(8):1919-1928. doi: 10.1038/s41409-021-01264-3. Epub 2021 Mar 25. PubMed PMID: 33767400.
AÑO: 2021; IF: 5.174
|
|
Novelli S, Bento L, Garcia I, Prieto L, Lopez L, Gutierrez G, Hernani R, Perez A, Esquirol A, Solano C, Bastos M, Dorado N, Rodriguez N, Rodriguez G, Pinana JL, Montoro J, Herrera P, Luna A, Parody R, Martin C, Garcia E, Lopez O, Heras I, Zanabili J, Moraleda JM, Yanez L, Gutierrez A, Zudaire T, Cordoba R, Varela R, Ferra C, Martinez J, Martinez C, Gonzalez-Barca E, Martino R, Caballero D; GELTAMO and GETH. Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers. Transplant Cell Ther. 2021 Jun;27(6):493.e1-493.e8. doi: 10.1016/j.jtct.2021.03.014. Epub 2021 Mar 15. PubMed PMID: 33857447.
AÑO: 2021; IF: 0.0
|